Vertical promotional banner for Kerry Health and Nutrition Institute webinar, “Feeding the Future: How climate, consumers and costs are reshaping food systems,” featuring smiling people in the background, a “Register Now” button, and podcast date listed as Tuesday, June 30th.
Albion Creatine MagnaPower banner with athletes training outdoors and the message, “The right partnership changes the game.”
Home
Jennewein Biotechnologie and...

Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components

30 Aug 2011
Add nutritioninsight as a preferred source on Google
Image

The partnership will focus on enabling the functional and immunological benefits of HMOs to become available to infants being fed with infant formulas.

Aug 30 2011 --- Jennewein Biotechnologie announced that the company has signed a license agreement with Pfizer Nutrition to develop and market two Human Milk Oligosaccharides (HMOs). 

Human Milk Oligosaccharides represent a major component of mother's milk, and provide short and long-term benefits to infants from birth onwards. Scientific research has shown that HMOs can significantly lower infants' risk of infection during the time of lactation. In addition, these compounds are known to influence colonization of beneficial bacteria and support healthy immune development.

The partnership will focus on enabling the functional and immunological benefits of HMOs to become available to infants being fed with infant formulas. Human milk, the "gold standard" due to its special composition of lipids, proteins and HMOs, is the best nutrition for infants.

"Building upon nearly a century as pioneers in infant nutritional science, we are constantly striving to more closely replicate the composition and functional benefits of breast milk, and this partnership truly helps further this mission," stated John Troup, PhD, Vice President, Global Research & Development, Pfizer Nutrition.

Dr. Stefan Jennewein, Managing Director and Cofounder of Jennewein Biotechnologie, underlines, "Complex oligosaccharides in general and HMOs in particular show an enormous potential for use in human nutrition. The cooperation between Pfizer Nutrition and Jennewein Biotechnologie will accelerate the developments in this field by bringing together specific complementary competencies."

Jennewein plans to also focus on adult nutrition, in addition to infant formulas, in the commercialization of HMOs so as to bring the benefits of this natural product to a broader group of consumers.

All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
Add nutritioninsight as a preferred source on Google
Save in your AIChatGPTGoogle AIClaudePerplexityGrok
Vertical promotional banner for Kerry Health and Nutrition Institute webinar, “Feeding the Future: How climate, consumers and costs are reshaping food systems,” featuring smiling people in the background, a “Register Now” button, and podcast date listed as Tuesday, June 30th.
Subscribe to our newsletters
PlatformsFood Ingredients FirstNutrition InsightPackaging InsightsPersonal Care InsightsThe World of Food Ingredients
About usContact usAdvertisingPrivacy statementSitemapArchive
Follow us
Image